Secondary Databased Post-marketing Surveillance Study of BNT162b2

NCT06743334 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2

Interventions

BIOLOGICAL: Tozinameran (BNT162b2)
BIOLOGICAL: Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1)
BIOLOGICAL: Tozinameran (BNT162b2) / Famtozinameran (BNT162b2 OMI BA.4-5)

Sponsor

Pfizer